

| 1. | imiglucerase(Cerezyme ) | ||
| 2. | miglustat(Zavesca ) | ||
| 3. | alglucerase(Ceredase ) | ||
Top
|
|||
|
IMIGLUCERASE (i mi GLOO ser ace) is a man-made form of an enzyme that is missing in patients with Gaucher's disease. It is used to treat the symptoms of Gaucher's disease. It is not a cure.
|
|
Long-term enzyme replacement therapy in adults and pediatric patients with confirmed diagnosis of nonneuronopathic (type 1) Gaucher’s disease that results in one or more of the following conditions: anemia, thrombocytopenia, bone disease, hepatomegaly, or splenomegaly (designated an orphan drug by FDA for this use).
|
|
MIGLUSTAT (MIG loo stat) helps to keep normal blood levels of an enzyme needed to breakdown fat in the body. It is used to treat type 1 Gaucher disease.
|
|
Management of mild to moderate nonneuronopathic (type 1) Gaucher’s disease in adults for whom enzyme replacement therapy is unsuitable (e.g., because of allergy, hypersensitivity, poor venous access).
|
|
ALGLUCERASE (al GLOO ser ace) is a drug that is used to replace an enzyme that is missing in patients with Gaucher's disease. It is used to treat the symptoms of Gaucher's disease. It is not a cure.
|
|
Long-term enzyme replacement therapy in patients with confirmed diagnosis of nonneuronopathic (type 1) Gaucher’s disease that results in one or more of the following conditions: moderate to severe anemia, thrombocytopenia with bleeding tendency, bone disease, and/or clinically important hepatomegaly or splenomegaly (designated an orphan drug by FDA for this use).
|


